500 Collins Street
Level 15
Melbourne, VIC 3000
Australia
61 3 9629 5566
https://www.paradigmbiopharma.com
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo:
Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.
La calificación ISS Governance QuickScore de Paradigm Biopharmaceuticals Limited a partir del 1 de junio de 2024 es 10. Las puntuaciones principales son Auditoría: 9; Junta: 10; Derechos del accionista: 1; Compensación: 8.